Evidence map›Paper›PMID 41996253›Full record

ReviewChemical reviews2026

High-Valent Late Transition Metal-Oxo Complexes: Breaking Boundaries at the Oxo Wall and Beyond.

Nabhendu Pal, Nicole A Fritsch, Jason Shearer, Nicolai Lehnert

Abstract readReview
In one paragraph

Review in Chemical reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Beyond the Oxo-Wall: Synthesis and Reactivity of a Six-Coordinate Formally CoAngewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nabhendu PalDepartment of Chemistry and Department of Biophysics, University of Michigan, Ann Arbor, Michigan 48109-1055, United States.
Nicole A FritschDepartment of Chemistry and Department of Biophysics, University of Michigan, Ann Arbor, Michigan 48109-1055, United States.
Jason ShearerDepartment of Chemistry, Trinity University, San Antonio, Texas 78212, United States.ORCID 0000-0001-7469-7304
Nicolai LehnertDepartment of Chemistry and Department of Biophysics, University of Michigan, Ann Arbor, Michigan 48109-1055, United States.ORCID 0000-0002-5221-5498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-valent first-row transition metal-oxo species are active intermediates in oxidation reactions crucial to many biological processes, oxidative chemical transformations in industry, and water splitting for renewable energy generation. The direct activation and hydroxylation of unactivated aliphatic C-H bonds remain a challenging yet important transformation in efficiently synthesizing complex organic molecules and pharmaceuticals with oxygenated functionalities. Despite documenting over 100 synthetic Fe-O species, terminal metal-oxo complexes involving the late transition metals Co, Ni, and Cu are much rarer, primarily due to the "oxo wall" phenomenon. The additional electrons in the metal-oxo unit weaken the M-O bond and destabilize these species. At the same time, as one traverses past the oxo wall, the M-O unit gains increasing amounts of metal-oxyl character, which holds promise for the generation of highly active catalysts for C-H bond activation, as exemplified by copper monooxygenase enzymes in nature. While forming late transition metal-oxo complexes is challenging, a few have been successfully prepared by targeting specific symmetries or unusual spin states. This review explores nonheme iron oxo complexes, the "oxo wall" concept, and recent advances in overcoming this limitation to prepare metal-oxo complexes of cobalt, nickel, and copper beyond the oxo wall.

Identifiers

PMID41996253
PMCPMC13178082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.